Market Tracker

08/29 5:16pm ET

GlaxoSmithKline PLC (NYSE:GSK)

43.61
Delayed Data
As of 4:02pm ET
 +0.06 / +0.14%
Today’s Change
36.71
Today|||52-Week Range
45.58
+9.63%
Year-to-Date
Better Buy: GlaxoSmithKline plc vs. AbbVie
9:42am / MotleyFool.com - Paid Partner Content
Top Research Reports for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
How Will GlaxoSmithKline (GSK) Stock React to New HIV Drug Development?
9:28am / TheStreet.com - Paid Partner Content
3 High-Yielding Healthcare Stocks I'm Not Buying
Aug 20 / MotleyFool.com - Paid Partner Content
3 High-Yield Dividend Stocks to Buy in September
Aug 27 / MotleyFool.com - Paid Partner Content
Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma
Aug 19 / Zacks.com - Paid Partner Content
Can Novartis Tide Over the Alcon Crisis?
Aug 26 / GuruFocus News - Paid Partner Content
Glaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study
Aug 17 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: GlaxoSmithKline, Blackstone Group, Mylan, Lululemo...
Aug 26 / Zacks.com - Paid Partner Content
Struggling in China, foreign firms seek to become more Chinese
Aug 02 / CNNMoney.com

Today’s Trading

Previous close43.55
Today’s open43.54
Day’s range43.39 - 43.70
Volume2,133,972
Average volume (3 months)3,239,903
Market cap$106.1B
Dividend yield5.05%
Data as of 4:02pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+14.25%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)-3.66%
P/E ratioNM
Price/Sales2.70
Price/Book13.98

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.10-0.15%
SNYSanofi+0.14+0.36%
BMYBristol-Myers Squibb-0.01-0.02%
AGNAllergan-1.28-0.54%
Data as of 4:02pm ET, 08/29/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)$0.76
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts